Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.13 USD | 0.00% | -2.89% | +64.87% |
14/05 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
13/05 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.87% | 262M | |
+47.36% | 54.63B | |
-6.53% | 39.92B | |
+37.07% | 38.82B | |
+13.36% | 26.86B | |
-11.17% | 26.22B | |
-21.63% | 18.78B | |
+25.10% | 12.21B | |
+0.73% | 12.16B | |
+25.61% | 11.94B |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Transcript : Inovio Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 09, 2021